Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Author's reply

Kardiol Pol. 2021;79(9):1050-1051. doi: 10.33963/KP.a2021.0071. Epub 2021 Jul 22.

¹ Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland.
² Department of Metabolic Diseases and Diabetology, Jagiellonian University Medical College, Kraków, Poland.
³ Department of Internal Diseases and Geriatrics, Jagiellonian University Medical College, Kraków, Poland.
⁴ Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland. [email protected].

No abstract available

Publication types